From particles to drug product performance and stability

March 21st 2023

Dr Daniel Markl from CMAC’s Digital Medicines Manufacturing research center (DM² ) co-hosted a webinar as part of a series run by the centre partner, Malvern Panalytical.

In this second webinar by DM², Daniel discussed the interplay between particle properties, formulation, microstructure and stability-related performance changes. He also provided insights into how these characteristics can be exploited to develop digitally driven design processes and how he and his team are doing this in their research for DM² Platform 2: Autonomous MicroScale Manufacturing.

If you missed the original session or wish to remind yourself of the useful learnings shared by Daniel, click below to watch a recording of the full webinar:

Steven Scott

We are twofifths design agency. We design logos, create unforgettable brands, design & build beautiful websites, and bring stories to life through animated motion graphics films.

http://www.twofifthsdesign.com
Previous
Previous

DM² Newsletter: Edition 3

Next
Next

Predicting pharmaceutical powder flow from microscopy images using deep learning